Effect of Dexmedetomidine and Remimazolam on Body Temperature in Patients Undergoing Spinal Anesthesia
Launched by SMG-SNU BORAMAE MEDICAL CENTER · Feb 24, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two medications, dexmedetomidine and remimazolam, affect body temperature in patients who are having surgery with spinal anesthesia. Spinal anesthesia is a way of numbing the lower part of the body, and the researchers want to see if these medications help keep patients' body temperatures stable during surgery.
To participate in the study, you need to be scheduled for elective surgery that will use spinal anesthesia. However, if you have severe vascular disease (problems with blood vessels) or thyroid dysfunction (issues with hormone production that can affect metabolism), you won’t be eligible. The trial is not yet recruiting participants, but if you qualify, you can expect to be monitored closely during your surgery to see how these medications impact your body temperature. This information could help improve care for patients undergoing similar procedures in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled for elective surgery under spinal anesthesia
- Exclusion Criteria:
- • Severe vascular disease
- • Thyroid dysfunction
About Smg Snu Boramae Medical Center
SMG-SNU Boramae Medical Center is a leading healthcare institution affiliated with Seoul National University, dedicated to advancing medical research and clinical innovation. As a prominent clinical trial sponsor, the center emphasizes multidisciplinary collaboration to enhance patient care and outcomes through rigorous scientific investigation. With state-of-the-art facilities and a commitment to ethical research practices, SMG-SNU Boramae Medical Center aims to address critical health challenges by facilitating the development of new therapies and improving existing treatment protocols. Its focus on patient-centered research ensures that clinical trials are designed to meet the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported